Standout Papers

Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China 2020 2026 2022 20241.3k
  1. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China (2020)
    Bo Li, Jing Yang et al. Clinical Research in Cardiology

Immediate Impact

2 from Science/Nature 61 standout
Sub-graph 1 of 22

Citing Papers

Neutrophil Membrane‐Camouflaged Polyprodrug Nanomedicine for Inflammation Suppression in Ischemic Stroke Therapy
2024 Standout
Loss of TRIM29 mitigates viral myocarditis by attenuating PERK-driven ER stress response in male mice
2024 Standout
2 intermediate papers

Works of Faming Zhao being referenced

Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
2020 Standout
Reversal of prolonged obesity-associated cerebrovascular dysfunction by inhibiting microglial Tak1
2020

Author Peers

Author Last Decade Papers Cites
Faming Zhao 115 74 53 977 549 22 1.5k
Yunhe Zhao 252 230 48 977 546 18 1.7k
Bo Li 53 47 20 976 544 9 1.3k
Hangyuan Guo 269 188 87 939 504 33 2.0k
Kaiming Wang 261 113 113 1084 524 20 1.7k
Anissa Viveiros 260 79 111 1054 494 14 1.6k
Zhe Dai 195 97 148 543 349 47 1.5k
Cong Zhang 119 211 74 1102 592 15 1.6k
Mingwei Bao 147 70 33 574 428 38 1.2k
Li Niu 256 298 134 1192 643 41 2.1k
Haijun Wang 97 58 42 854 503 15 1.3k

All Works

Loading papers...

Rankless by CCL
2026